BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27660294)

  • 1. Cathepsin G Controls Arterial But Not Venular Myeloid Cell Recruitment.
    Ortega-Gomez A; Salvermoser M; Rossaint J; Pick R; Brauner J; Lemnitzer P; Tilgner J; de Jong RJ; Megens RT; Jamasbi J; Döring Y; Pham CT; Scheiermann C; Siess W; Drechsler M; Weber C; Grommes J; Zarbock A; Walzog B; Soehnlein O
    Circulation; 2016 Oct; 134(16):1176-1188. PubMed ID: 27660294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of Talin1 in Myeloid Cells Facilitates Atherosclerosis in Mice.
    Shi H; Song J; Gao L; Shan X; Panicker SR; Yao L; McDaniel M; Zhou M; McGee S; Zhong H; Griffin CT; Xia L; Shao B
    Arterioscler Thromb Vasc Biol; 2024 Jun; ():. PubMed ID: 38899470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homogeneous, Synthetic, Non-Saccharide Glycosaminoglycan Mimetics as Potent Inhibitors of Human Cathepsin G.
    Afosah DK; Fayyad RM; Puliafico VR; Merrell S; Langmia EK; Diagne SR; Al-Horani RA; Desai UR
    Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathepsin G-mediated proteolytic degradation of MHC class I molecules to facilitate immune detection of human glioblastoma cells.
    Palesch D; Wagner J; Meid A; Molenda N; Sienczyk M; Burkhardt J; Münch J; Prokop L; Stevanovic S; Westhoff MA; Halatsch ME; Wirtz CR; Zimecki M; Burster T
    Cancer Immunol Immunother; 2016 Mar; 65(3):283-91. PubMed ID: 26837514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substituted 4H-3,1-benzoxazine-4-one Derivatives as Inhibitors of Cathepsin G.
    Aliter KF; Al-Horani RA
    Med Chem; 2024 Apr; ():. PubMed ID: 38676528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights from Murine Studies on the Site Specificity of Atherosclerosis.
    Getz GS; Reardon CA
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting immune cell recruitment in atherosclerosis.
    Döring Y; van der Vorst EPC; Weber C
    Nat Rev Cardiol; 2024 Apr; ():. PubMed ID: 38664575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an SPR imaging biosensor for determination of cathepsin G in saliva and white blood cells.
    Gorodkiewicz E; Regulska E; Wojtulewski K
    Mikrochim Acta; 2011 Jun; 173(3-4):407-413. PubMed ID: 21660086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular CXCR4 Limits Atherosclerosis by Maintaining Arterial Integrity: Evidence From Mouse and Human Studies.
    Döring Y; Noels H; van der Vorst EPC; Neideck C; Egea V; Drechsler M; Mandl M; Pawig L; Jansen Y; Schröder K; Bidzhekov K; Megens RTA; Theelen W; Klinkhammer BM; Boor P; Schurgers L; van Gorp R; Ries C; Kusters PJH; van der Wal A; Hackeng TM; Gäbel G; Brandes RP; Soehnlein O; Lutgens E; Vestweber D; Teupser D; Holdt LM; Rader DJ; Saleheen D; Weber C
    Circulation; 2017 Jul; 136(4):388-403. PubMed ID: 28450349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of NET Release Fails to Reduce Adipose Tissue Inflammation in Mice.
    Braster Q; Silvestre Roig C; Hartwig H; Beckers L; den Toom M; Döring Y; Daemen MJ; Lutgens E; Soehnlein O
    PLoS One; 2016; 11(10):e0163922. PubMed ID: 27701440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chrono-pharmacological Targeting of the CCL2-CCR2 Axis Ameliorates Atherosclerosis.
    Winter C; Silvestre-Roig C; Ortega-Gomez A; Lemnitzer P; Poelman H; Schumski A; Winter J; Drechsler M; de Jong R; Immler R; Sperandio M; Hristov M; Zeller T; Nicolaes GAF; Weber C; Viola JR; Hidalgo A; Scheiermann C; Soehnlein O
    Cell Metab; 2018 Jul; 28(1):175-182.e5. PubMed ID: 29861387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian Control of Inflammatory Processes in Atherosclerosis and Its Complications.
    Steffens S; Winter C; Schloss MJ; Hidalgo A; Weber C; Soehnlein O
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1022-1028. PubMed ID: 28450299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokine interactome mapping enables tailored intervention in acute and chronic inflammation.
    von Hundelshausen P; Agten SM; Eckardt V; Blanchet X; Schmitt MM; Ippel H; Neideck C; Bidzhekov K; Leberzammer J; Wichapong K; Faussner A; Drechsler M; Grommes J; van Geffen JP; Li H; Ortega-Gomez A; Megens RT; Naumann R; Dijkgraaf I; Nicolaes GA; Döring Y; Soehnlein O; Lutgens E; Heemskerk JW; Koenen RR; Mayo KH; Hackeng TM; Weber C
    Sci Transl Med; 2017 Apr; 9(384):. PubMed ID: 28381538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophils as protagonists and targets in chronic inflammation.
    Soehnlein O; Steffens S; Hidalgo A; Weber C
    Nat Rev Immunol; 2017 Apr; 17(4):248-261. PubMed ID: 28287106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective Aptitude of Annexin A1 in Arterial Neointima Formation in Atherosclerosis-Prone Mice-Brief Report.
    de Jong RJ; Paulin N; Lemnitzer P; Viola JR; Winter C; Ferraro B; Grommes J; Weber C; Reutelingsperger C; Drechsler M; Soehnlein O
    Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):312-315. PubMed ID: 28062503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil Extracellular Traps in Atherosclerosis and Atherothrombosis.
    Döring Y; Soehnlein O; Weber C
    Circ Res; 2017 Feb; 120(4):736-743. PubMed ID: 28209798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Neutrophil Peptide 1 Limits Hypercholesterolemia-induced Atherosclerosis by Increasing Hepatic LDL Clearance.
    Paulin N; Döring Y; Kooijman S; Blanchet X; Viola JR; de Jong R; Mandl M; Hendrikse J; Schiener M; von Hundelshausen P; Vogt A; Weber C; Bdeir K; Hofmann SM; Rensen PCN; Drechsler M; Soehnlein O
    EBioMedicine; 2017 Feb; 16():204-211. PubMed ID: 28111237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophils as regulators of cardiovascular inflammation.
    Silvestre-Roig C; Braster Q; Ortega-Gomez A; Soehnlein O
    Nat Rev Cardiol; 2020 Jun; 17(6):327-340. PubMed ID: 31996800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of vascular remodeling by immune microenvironment after the establishment of autologous arteriovenous fistula in ESRD patients.
    Zhang Y; Kong X; Liang L; Xu D
    Front Immunol; 2024; 15():1365422. PubMed ID: 38807593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophils in Physiology and Pathology.
    Aroca-Crevillén A; Vicanolo T; Ovadia S; Hidalgo A
    Annu Rev Pathol; 2024 Jan; 19():227-259. PubMed ID: 38265879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.